Cardinal Health Inc (CAH) stock
CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3042% above fair value
$279.25−4.60 (-1.62%)
Close on Nov 17, 2026Market cap $64.95BP/E 38.6Yield 0.73%
Cardinal Health total assets
Total assets on the balance sheet at the end of each period.
Cardinal Health's total assets was $57.30B at Jun 30, 2026. For fiscal 2026 it was $57.30B, up 7.9% from the year before. Over ten years it grew 5.3% a year on average. The highest annual figure on record is $57.30B in fiscal 2026.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $57.30B | +7.9% |
| FY2025 | Jun 30, 2025 | $53.12B | +17.7% |
| FY2024 | Jun 30, 2024 | $45.12B | +4.1% |
| FY2023 | Jun 30, 2023 | $43.35B | -1.2% |
| FY2022 | Jun 30, 2022 | $43.88B | -1.3% |
| FY2021 | Jun 30, 2021 | $44.45B | +9.0% |
| FY2020 | Jun 30, 2020 | $40.77B | -0.5% |
| FY2019 | Jun 30, 2019 | $40.96B | +2.5% |
| FY2018 | Jun 30, 2018 | $39.95B | -0.4% |
| FY2017 | Jun 30, 2017 | $40.11B | +17.6% |
| FY2016 | Jun 30, 2016 | $34.12B | +13.2% |
| FY2015 | Jun 30, 2015 | $30.14B | +15.8% |
| FY2014 | Jun 30, 2014 | $26.03B | +0.8% |
| FY2013 | Jun 30, 2013 | $25.82B | +6.4% |
| FY2012 | Jun 30, 2012 | $24.26B | +6.2% |
| FY2011 | Jun 30, 2011 | $22.85B | +14.3% |
| FY2010 | Jun 30, 2010 | $19.99B | -20.4% |
| FY2009 | Jun 30, 2009 | $25.12B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $57.30B | +7.9% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $56.69B | +13.7% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $58.08B | +23.6% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $55.23B | +28.3% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $53.12B | +17.7% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $49.87B | +8.7% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $47.00B | +0.9% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $43.06B | -1.5% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $45.12B | +4.1% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $45.88B | +5.8% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $46.57B | +4.7% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $43.71B | +0.7% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $43.35B | -1.2% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $43.38B | +3.0% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $44.48B | +1.8% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $43.39B | +0.9% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $43.88B | -1.3% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $42.11B | -4.0% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $43.68B | -2.3% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $42.99B | +3.0% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $44.45B | +9.0% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $43.87B | +6.6% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $44.72B | +9.0% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $41.73B | +6.5% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $40.77B | -0.5% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $41.15B | +0.8% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $41.04B | +1.4% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $39.18B | -2.1% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $40.96B | +2.5% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $40.81B | -0.5% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $40.46B | -5.7% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $40.01B | -4.6% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $39.95B | -0.4% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $41.03B | +20.1% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $42.91B | +22.5% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $41.94B | +21.9% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $40.11B | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $34.17B | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $35.02B | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $34.41B | – |
See a number that looks wrong?